BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Drug Development

  Celldex Presents Data On New Product Candidate, CDX-1140, A Novel CD40 Agonist Antibody

  November 14, 2016

   · 

  5 min read
• Drug Development

  Reata Pharmaceuticals, Inc. Announces Plan for Global Phase II/III Trial in Chronic Kidney Disease Caused by Alport Syndrome

  November 14, 2016

   · 

  12 min read
• Pharm Country

  Actinium Announces Notice Of Allowance For U.S. Patent Related To Actimab-A

  November 14, 2016

   · 

  4 min read
• BioMidwest

  Crescendo Bioscience Announces Four Studies With Vectra DA Will Be Presented At The American College of Rheumatology 2016 Annual Meeting

  November 14, 2016

   · 

  11 min read
• BioMidwest

  AbbVie’s HUMIRA (Adalimumab) Receives CHMP Positive Opinion To Treat Adolescents With Hidradenitis Suppurativa, A Chronic Inflammatory Skin Disease

  November 14, 2016

   · 

  6 min read
• Drug Development

  Boston Biomedical Announces Orphan Drug Designation For Napabucasin In Pancreatic Cancer

  November 14, 2016

   · 

  5 min read
• Business

  Vigilant Biosciences Announces New Distribution Partnership Agreements For OncAlert Oral Cancer Product Line For Spain, Portugal And Germany

  November 14, 2016

   · 

  6 min read
• Genetown

  American Association for Study of Liver Diseases Release: Statins Shown To Reduce Risk Of Death In People With Alcoholic Cirrhosis

  November 14, 2016

   · 

  4 min read
• Genetown

  American Association for Study of Liver Diseases Release: Large Study Identifies Increase Of Cirrhosis In Hepatitis C Patients

  November 14, 2016

   · 

  4 min read
• Drug Development

  Eiger Biopharma Announces Positive Phase 2 Data At The American Association for Study of Liver Diseases Meeting: Multiple Paths Forward Identified With Lonafarnib Therapy In LOWR HDV Program

  November 14, 2016

   · 

  11 min read